fenofibrate has been researched along with Cerebrovascular Disorders in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment by simvastatin and fenofibrate prevented CPB-induced endothelial dysfunction." | 1.43 | Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass. ( Amr, G; Azzaoui, R; Bordet, R; Delassus, L; Fossaert, E; Modine, T; Ouk, T; Tailleux, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitajima, S | 1 |
| Furuichi, K | 1 |
| Wada, T | 1 |
| Ouk, T | 1 |
| Amr, G | 1 |
| Azzaoui, R | 1 |
| Delassus, L | 1 |
| Fossaert, E | 1 |
| Tailleux, A | 1 |
| Bordet, R | 1 |
| Modine, T | 1 |
1 review available for fenofibrate and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Impact of dyslipidemia on the onset and progression of diabetic complications].
Topics: Cerebrovascular Disorders; Coronary Disease; Diabetic Angiopathies; Diabetic Nephropathies; Dyslipid | 2013 |
1 other study available for fenofibrate and Cerebrovascular Disorders
| Article | Year |
|---|---|
Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass.
Topics: Animals; Avoidance Learning; Cardiopulmonary Bypass; Cerebrovascular Disorders; Cognition Disorders; | 2016 |